BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress

The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...

June 21, 2023 | News

Sirnaomics Advances STP705 for SCCIS into Late-Stage Clinical Development

The FDA provided Sirnaomics guidance to move forward with late-stage clinical development because of the efficacious data provided as well as the widesprea...

June 20, 2023 | News

Singleron introduces new instruments to streamline single cell analysis workflow

Scientists and clinical researchers appreciate the prospect of portable instruments that easily fit into any laboratory, whilst delivering results that are...

June 16, 2023 | News

Gilead Sciences Singapore Discusses Access and Affordability of CAR T-Cell Therapy in Singapore and Beyond

Can you elaborate on the current availability and accessibility of CAR T-cell therapies in Singapore? What are the key considerations or barriers that need...

June 19, 2023 | News

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

"The initiation of our FIH clinical trial with MDR-001 is an important milestone for MindRank which is yet another great validation of the potential of our...

June 15, 2023 | News

Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform

NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...

June 14, 2023 | News

Lunit's Groundbreaking AI Research Transforms Medical Pathology with Computer Vision, Presented at CVPR 2023

Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, announced its participation in the Conference on Computer...

June 13, 2023 | News

Coya Therapeutics Shows Neuroinflammation Decrease with COYA 301 in Alzheimer's

- Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to mod...

June 08, 2023 | News

Merck Announces Proteologix as Winner of its North American Advance Biotech Grant

Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from Me...

June 07, 2023 | News

Acepodia Secures $100 Million Series D Financing to Advance

Series D led by Digital Mobile Venture with participation from additional existing investors Funds will support expansion and progress of oncology pipelin...

June 07, 2023 | News

Gencurix Announces Clinical Research Results At ASCO 2023

Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly compa...

June 06, 2023 | News

Massive Bio and TOI Partner to Revolutionize Cancer Care and Research

Under this visionary collaboration, Massive Bio will support TOI with evaluating the eligibility of patients for TOI's active clinical ...

June 05, 2023 | News

YS Biopharma's PIKA Rabies Vaccine Approved for Phase 3 Clinical Trials by Philippines FDA

The Phase 3 clinical trial, which is planned to commence later in 2023, is a multi-center, multi-country study designed to evaluate the safety and immunoge...

June 02, 2023 | News

Aravax doses first patient in Phase 2 peanut allergy clinical trials

Allergy clinical trial centres across Victoria, South Australia, New South Wales, and Western Australia have invited children and ...

June 02, 2023 | News

Stay Connected